Literature DB >> 10406899

Secondary chromosome changes in mantle cell lymphoma.

I Wlodarska1, S Pittaluga, A Hagemeijer, C De Wolf-Peeters, H Van Den Berghe.   

Abstract

BACKGROUND AND
OBJECTIVE: Mantle cell lymphomas (MCLs) comprise a rare but distinct clinicopathological entity usually associated with t(11;14). This translocation is regarded as a primary event, but it has been suggested that other as yet unidentified genetic alterations are required for development and progression of MCL. DESIGN AND METHODS: In order to identify recurrent secondary changes that might point towards specific chromosomal regions contributing to the pathogenesis of MCL we studied 43 MCL cases in which clonal chromosomal abnormalities have been found during cytogenetic analysis.
RESULTS: In this series 83% of cases were characterized by t(11;14) and in the majority of them the t(11;14) was associated with multiple other chromosomal aberrations. Recurrent secondary changes were found in which imbalances of genetic material prevailed, losses being more common than gains. The former involved thirteen chromosomes, especially 13, 6q, 9q, 11q, 8/8p, 10/10p, and 14, whereas recurrent gains affected 3/3q. Non-randomly occurring breakpoints were relatively infrequent. The identified anomalies were also involved in aberrations observed in the group of MCL not associated with t(11;14). Some of them are shared with other B-cell proliferations. INTERPRETATION AND
CONCLUSIONS: The data presented here indicate that MCL is characterized by consistently occurring secondary chromosome changes. Their significance for the development and/or progression of MCL needs to be elucidated and confirmed by further investigations.

Entities:  

Mesh:

Year:  1999        PMID: 10406899

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  6 in total

1.  Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.

Authors:  Vilmos A Thomázy; Rajyalakshmi Luthra; Margaret O Uthman; Peter J A Davies; L Jeffrey Medeiros
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

2.  Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.

Authors:  Itziar Salaverria; Andreas Zettl; Sílvia Beà; Victor Moreno; Joan Valls; Elena Hartmann; German Ott; George Wright; Armando Lopez-Guillermo; Wing C Chan; Dennis D Weisenburger; Randy D Gascoyne; Thomas M Grogan; Jan Delabie; Elaine S Jaffe; Emili Montserrat; Hans-Konrad Muller-Hermelink; Louis M Staudt; Andreas Rosenwald; Elias Campo
Journal:  J Clin Oncol       Date:  2007-02-12       Impact factor: 44.544

3.  Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14.

Authors:  A Aventín; J Nomdedéu; J Briones; I Espinosa; R Bordes; J Sierra
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

4.  A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.

Authors:  Michael R Green; Paul Jardine; Peter Wood; Jeremy Wellwood; Rod A Lea; Paula Marlton; Lyn R Griffiths
Journal:  BMC Cancer       Date:  2010-05-12       Impact factor: 4.430

5.  MicroRNA-17-92 significantly enhances radioresistance in human mantle cell lymphoma cells.

Authors:  Ping Jiang; En Y Rao; Na Meng; Yong Zhao; Jun J Wang
Journal:  Radiat Oncol       Date:  2010-11-01       Impact factor: 3.481

6.  De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly.

Authors:  Ghaleb Elyamany; Ali Matar Alzahrani; Eman Al Mussaed; Hassan Aljasem; Sultan Alotaibi; Hatem Elghezal
Journal:  Case Rep Hematol       Date:  2015-08-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.